While REMS programs are intended to mitigate risk, a number of factors can make proper deployment difficult. This week’s ISMP featured newsletter article, part one of a two-part series, highlights some of the REMS-related problems reported to ISMP: https://www.ismp.org/node/87562
ISMP is conducting a short survey to get a sense of the current level of implementation of the 2022-2023 Targeted Medication Safety Best Practices for Hospitals. We would very much appreciate your participation in this survey. Please complete this survey online by June 30, 2023, by visiting: www.ismp.org/ext/1164. The findings will also be described when introducing the new 2024-2025 Targeted Medication Safety Best Practices for Hospitals early in 2024.
The third episode ISMP’s medication safety podcast series focuses on how to reduce the risk of patient harm and medication errors associated with inappropriate polypharmacy. To watch: https://www.ismp.org/events/perils-polypharmacy
This week’s ISMP featured newsletter article provides recommendations for preventing errors when pediatric patients need to be treated in settings that are not designated solely for children: https://www.ismp.org/node/82964
An International Medication Safety Network (IMSN) special interest group chaired by ISMP recently published recommendations for global implementation of safe oxytocin use practices: https://www.intmedsafe.net/imsn-oxytocin-sig-issues-recommendations-for-...